Cheng C P, Noda T, Nordlander M, Ohno M, Little W C
Section of Cardiology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
J Pharmacol Exp Ther. 1994 Mar;268(3):1232-41.
We compared the effects of three dihydropyridine calcium antagonists (felodipine, nifedipine and amlodipine) on left ventricular (LV) contractile performance and diastolic filling dynamics in eight conscious animals. After administering metoprolol and atropine, felodipine (25 nmol/kg i.v.) produced significant decreases in LV end-systolic pressure (PES) (109 +/- 15 vs. 88 +/- 12 mmHg, P < .05) and arterial elastance (Ea) (12.6 +/- 4.5 vs. 8.5 +/- 3.4 mmHg/ml, P < .05), whereas the heart rate was unchanged. Felodipine increased the slopes of the end-systolic P-V relation (7.4 +/- 0.9 vs. 9.9 +/- 1.0 mmHg/ml, P < .05), the dP/dtmax-end diastolic volume (VED) relation (68.1 +/- 11.2 vs. 94.9 +/- 14.3 mmHg/sec/ml, P < .05), and the stroke work (SW)-VED relation (72.1 +/- 3.1 vs. 82.8 +/- 5.2 mmHg, P < .05), and shifted all three relations to the left, indicating enhanced contractile performance. In contrast, at doses that produced equivalent reductions of PES, nifedipine (375 nmol/kg i.v.) and amlodipine (780 nmol/kg i.v.), significantly decreased the slopes of the end-systolic P-V relation, the dP/dtmax-VED relation and the SW-VED relation and shifted all three relations to the right, indicating depressed LV contractile performance. Felodipine decreased the time constant (T) of LV relaxation (32.2 +/- 5.2 to 28.8 +/- 5.2 msec, P < .05) and increased the maximum rate of early diastolic LV filling (dV/dtmax) (167 +/- 22 to 207 +/- 26 ml/sec, P < .05). Amlodipine had the opposite effect, slowing T (31.0 +/- 4.9 to 33.9 +/- 5.4 msec, P < .05) and decreasing dV/dtmax (173 +/- 39 to 154 +/- 30 ml/sec, P < .05), whereas nifedipine had no significant effects on T, PGmax or dV/dtmax. Thus, we conclude that in conscious dogs after autonomic blockade, at dosages that produced equivalent arterial vasodilation, felodipine augmented, whereas amlodipine depressed, LV contractile performance, LV relaxation and early LV filling. Nifedipine decreased LV contractile performance but had no significant effect on LV relaxation and early LV filling.
我们比较了三种二氢吡啶类钙拮抗剂(非洛地平、硝苯地平和氨氯地平)对8只清醒动物左心室(LV)收缩性能和舒张充盈动力学的影响。给予美托洛尔和阿托品后,非洛地平(静脉注射25 nmol/kg)使左心室收缩末期压力(PES)显著降低(109±15 vs. 88±12 mmHg,P<.05),动脉弹性(Ea)显著降低(12.6±4.5 vs. 8.5±3.4 mmHg/ml,P<.05),而心率未改变。非洛地平增加了收缩末期压力-容积关系的斜率(7.4±0.9 vs. 9.9±1.0 mmHg/ml,P<.05)、dP/dtmax-舒张末期容积(VED)关系的斜率(68.1±11.2 vs. 94.9±14.3 mmHg/秒/ml,P<.05)以及每搏功(SW)-VED关系的斜率(72.1±3.1 vs. 82.8±5.2 mmHg,P<.05),并使这三种关系均向左移位,表明收缩性能增强。相比之下,在产生等效PES降低的剂量下,硝苯地平(静脉注射375 nmol/kg)和氨氯地平(静脉注射780 nmol/kg)显著降低了收缩末期压力-容积关系的斜率、dP/dtmax-VED关系的斜率和SW-VED关系的斜率,并使这三种关系均向右移位,表明左心室收缩性能降低。非洛地平降低了左心室舒张的时间常数(T)(从32.2±5.2毫秒降至28.8±5.2毫秒,P<.05),并增加了左心室舒张早期最大充盈率(dV/dtmax)(从167±22毫升/秒增至207±26毫升/秒,P<.05)。氨氯地平则有相反的作用,使T减慢(从31.0±4.9毫秒增至33.9±5.4毫秒,P<.05),并降低dV/dtmax(从173±39毫升/秒降至154±30毫升/秒,P<.05),而硝苯地平对T、PGmax或dV/dtmax无显著影响。因此,我们得出结论,在自主神经阻断后的清醒犬中,在产生等效动脉血管舒张的剂量下,非洛地平增强了左心室收缩性能、左心室舒张和左心室早期充盈,而氨氯地平则抑制了这些功能。硝苯地平降低了左心室收缩性能,但对左心室舒张和左心室早期充盈无显著影响。